International Congress on Neuromuscular Diseases 2022 (ICNMD)

Back

DYNE-101 Corrects the DM1 Splicing Phenotype Of hTfR1/DMSXL Mice and is Well Tolerated in NHP (poster)

View

FORCE™ Platform Demonstrates Durable Dystrophin Expression in mdx Mice and Favorable Safety Profile in NHPs (poster)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.